SIGNIFICANCE STATEMENT
As a highly prominent epigenetic mark that is associated with gene activation and a number of neurodevelopmental disorders in human, the role of histone H3K4 methylation in the fate determination of neural stem cells is unclear. Result of this study uncover a profound role of this epigenetic modification in the fundamental properties of postnatal neural stem cells, including selfrenewal and differentiation, and may have implications for a better understanding and treatment of a broad spectrum of neurodevelopmental disorders associated with H3K4 methylation modulators.
INTRODUCTION
The capacity of self-renewal and differentiation is the defining property of all stem cells including neural stem cells (NSCs) [1, 2] . The maintenance and alteration of stem cell fate are ultimately controlled at the level of gene expression, which is profoundly shaped by the global and local chromatin state. Epigenetic mechanisms, including histone methylation, are increasingly linked to NSC fate determination [3] [4] [5] . Histone H3K4 and H3K27 methylation marks are a paradigm of two oppositely acting epigenetic mechanisms on gene expression [6, 7] . Both the writer and eraser of H3K27 methylation regulates the self-renewal and/or differentiation of NSCs [8] [9] [10] . Bmi1, a Polycomb family protein involved in linking H3K27 methylation to gene repression, is required for NSC self-renewal partly through repressing Ink4a/Arf [11, 12] . On the other hand, the role of H3K4 methylation in NSC fate determination is relatively less understood, despite being a prominent mark generally associated with and functionally important for gene activation [13] [14] [15] [16] . Mutations of several writers, erases, and readers of this chromatin modification are associated with some human neurodevelopmental disorders [17] , but a role of this modification in these disease processes is unknown. In mammalian cells, H3K4 methylation is mainly catalyzed by the Set1/Mll complexes, which comprise one of the Setd1a, Setd1b, Kmt2a/Mll1, Kmt2b/Mll2, Kmt2c/Mll3, and Kmt2d/Mll4 proteins as the catalytic subunit and all of the Wdr5, Rbbp5, Ash2l, and Dpy30 proteins as the common core subunits [18, 19] . Among these subunits, Mll1 has been shown to be required for postnatal neurogenesis, but not gliogenesis [20] . However, no reduction in H3K4 methylation was found either globally or at local genes in Mll1-deficient brain cells [20] , suggesting that other activities of Mll1 underlie its role in neurogenesis. Thus, the function of H3K4 methylation in NSC self-renewal and lineage determination remains unknown.
We have previously established a direct role of the Dpy30 subunit of the Set1/Mll complexes in facilitating genome-wide H3K4 methylation [21] , and also used an unbiased biochemical approach to show that Set1/Mll complex components are the major proteins associated with Dpy30 [14] . These results allow us to investigate the function of efficient H3K4 methylation in various biological processes by perturbing Dpy30's activity. Interestingly, Dpy30 and efficient H3K4 methylation are not essential for the self-renewal of embryonic stem cells (ESCs), but required for efficient retinoic acid-mediated differentiation of ESCs to neurons and induction of numerous neuronal lineage genes during differentiation [21] . H3K4 methylation conveys plasticity of the transcriptional program during stem cell fate transition [21] , and this is further supported by its requirement in efficient reprogramming of differentiated fibroblasts back to the pluripotent state For NeuN quantification, positive nuclear staining was counted. For quantification of all SVZ staining except Gfap and Ki-67, total area and area of positive staining was measured using ImageJ (NIH image analysis software, https://imagej.nih.gov/) 'measure tool' that provides user with an 'area count' in arbitrary units. The area of positive staining was then divided by total area of SVZ to report the ratio. For Gfap quantification, the cells right above the DG and SVZ structure showing radial tubular projection staining were counted. For Ki-67 quantification in both DG and SVZ, red dots within the DG and SVZ were counted. No NeuN was found in the SVZ of control or KO mice.
Western blotting
Whole fractionated brain cells were lysed by SDS loading buffer (2% SDS, 0.1% Bromophenol blue, 10% glycerol, 100mM DTT, and 50 mM Tris-Cl, pH 6.8) and boiled for 7 minutes. Proteins were resolved on SDS-PAGE gel followed by Western blotting using previously described antibodies [21] for H3, H3K4me1, and H3K4me2, or H3K4me3 (same as used for immunostaining), and Gapdh (EMD Millipore MAB374). Key signals were quantified using ImageJ program (https://imagej.nih.gov/) followed by subtraction of a blank area and normalization to the indicated reference signal intensity.
Neurosphere Assays
Isolation: Progenitors were isolated from 12 days old SVZ tissue using 0.05% trypsin.
Neurospheres were grown on non-tissue culture treated plates with mouse NeuroCult proliferation media (Stem Cell Technologies; Seattle, WA) containing 10 ng/ml bFGF, (ProSpec, East Brunswick, NJ), 10 ng/ml EGF (ProSpec), and 2 μg/ml heparin (Fisher Scientific). In the case of progenitors isolated from 12 days old hippocampi, cells from KO mice brain did not grow at all in culture and hence could not be used in serial re-plating or differentiation assays described below.
Serial re-plating assay: The process of the directly isolated progenitors (as explained above) in proliferation media for 7 days is defined as "passage 0". Neurospheres were dissociated using Accutase (Fisher Scientific). Single cell dissociation was plated in 6-well (non-tissue culture treated) plates at 20,000 cells/well in 2 ml of complete proliferation media (thus 10 cells/µl). 7 days later (at passage 1) primary neurosphere number per well was counted and their diameters were measured. Following evaluation, primary neurospheres were collected, dissociated, and re-plated at 10,000 cells/well (thus 5 cells/µl). Secondary sphere number and size were evaluated 7 days later (at passage 2). Secondary spheres were again dissociated and re-plated at 5,000 cells/well (thus 2.5 cells/µl) for 3 more passages to further evaluate self-renewal. Images of neurospheres were taken on a Nikon Eclipse Ti-S inverted microscope system and the diameter of each sphere was measured manually from images using a ruler (and scale bar from images for conversion 2.5 cm = 100 μm for images taken with a 10x objective). Neurospheres at passage 0 were not characterized because of concern of non-clonality and variation in the number of the initiating cells due to variation in the amount of dissected tissue out of control and KO brain. Counting neurospheres for passages 1 and 2 was performed by sampling 100 μl of culture under microscope. The number of neurospheres counted in 100 μl of culture was then multiplied by 20
to get an estimation of total neurospheres in 2ml media. Counting for passages 3-5 was performed from images since the neurospheres then became fewer and could be captured by multiple nonoverlapping images covering the whole area of a well.
Differentiation assay: Neurospheres at passage 3 were dissociated and plated at 10,000 cells/well in Poly-L-ornithine (Sigma, P3655) and Laminin (Millipore CC095) coated plates in differentiation media (NeuroCult media without growth factors). Staining was performed as described for coronal sections in immunofluorescence protocol at 10 days in differentiation media. Images were taken as described in Serial re-plating assay.
NPC culture, gene knockdown (KD), growth, differentiation, and chromatin immunoprecipitation (ChIP) assays
For stable KD, ReNcell VM (Millipore, SCC008) and NE-4C (ATCC, CRL-2925) cells were grown and maintained as recommended by the vendor's protocol. ReNcell VM is an immortalized human neuronal progenitor cell line derived from ventral mesencephalon of human fetal brain and has the ability to readily differentiate into neurons and glia cells. NE-4C is a neuroepithelial cell line derived from cerebral vesicles of 9-day old mouse p53 -/-embryos that differentiate into neurons upon induction with retinoic acid [24] . These cells were infected with lentiviruses expressing control or human or mouse Dpy30 shRNAs [all sequences are available in [25] ], or human ASH2L
shRNA (5'-CCTGCTTGTATGAACGGGTTT-3'), followed by selection using 2 μg/ml of puromycin (Invivogen, 58-58-2) for 2-3 days starting from 2 days after infection. Live cells were counted using Trypan blue (Gibco, 15250061) exclusion. Cells were then used for RT-qPCR analysis,
ChIP-qPCR analysis, and differentiation assays.
For NPC growth assays, puromycin-selected cells were plated at 10,000 cells/ml in the cell maintenance media in the absence of selecting antibiotic to exclude the possibility of altered expression of antibiotic-resistance gene, and number of live cells was counted using a hemocytometer on indicated days. For NPC differentiation assays, puromycin selected cells were plated at 100,000 cells/well in a 12-well plate and maintained at 1.2 μg/ml puromycin. ReNcell VM cells were cultured in differentiation media that consists of cell maintenance media with puromycin, but without growth factors. NE-4C cells were differentiated by adding 1 μM all-trans retinoic acid (Sigma, 302-79-4) to the culture media with puromycin. Nine days into differentiation, cells were counted, harvested for RNA isolation and measurement of mRNA levels, and stained as described for coronal section staining in Immunofluorescence protocol. Quantification was performed on images taken from 3 independent assays. In dual staining assays, completely overlapping yellow dots were not counted. Partially overlapping yellow dots were counted as 1 for neuron and 1 for glia since these are different cells growing partially on top of each other.
NPC ChIP assays were performed as previously described [21] . For quantifications of ChIP results, percent input was first calculated from ChIP qPCR data as previously described [21] , and the relative enrichment fold was calculated as the ratio of the percent input value for each locus over that for the Map2 or MAP2 locus in the scramble control cells (which was set to 1). Table S3 . Relative expression levels were normalized to indicated genes in the figure legends.
Total RNAs were sent to the Genomic Services Lab at the HudsonAlpha Institute for Biotechnology (Huntsville, AL) for sequencing, including library construction. In brief, the quality of the total RNA and DNA was assessed using the Agilent 2100 Bioanalyzer. Two rounds of polyA+ selection was performed for RNA samples, followed by conversion to cDNAs. We used Briefly, low quality mapped reads (MQ < 30) were removed from the analysis, mapped to the mouse reference genome (mm10) using TopHat2 (v2.1.0), and annotated using Gencode v20
(changed parameter "Strand Specificity" set to "Auto detect" [26] [27] [28] [29] [30] [31] . Gene sets enriched in quiescent NSC population or activated NSC population were from [32] . Genes were rank-ordered in descending order according to the fold change. The list of pre-ranked genes was analyzed with the gene set matrix composed file (.gmx) from curated data. Significant gene sets enriched by Dpy30 KD were identified using nominal P value < 0.05 and FDR value < 0.1. All analyses were performed using GSEA v2.0 software with pre-ranked list and 1000 data permutations.
Our RNA-seq datasets have been deposited in the Gene Expression Omnibus database under GSE114091.
Statistics
All data are reported as mean ± SD. Unless indicated otherwise in legends, unpaired and equal variance, two-tailed Student's t test was used to calculate P-values and evaluate the statistical significance of the difference between control and KO samples in all comparisons. F-test was used to determine if variances are equal. P value less than 0.05 was considered significant. For Figure 3D left and middle panels, a Mann-Whitney U test was performed to evaluate the difference between control and KO neurosphere number and subsequent drop between consecutive passages at alpha 0.05. For Figures 4B, 4F , and S4C, all samples comparison was performed using Two-factor ANOVA with replication, followed by post hoc t-Test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, and *****P < 0.00001.
Video
Video was recorded using iPhone 6 camera.
RESULTS

Expression of Dpy30 in the developing brain
To learn the expression pattern of Dpy30 in the developing mammalian brain, we mined a collection of in situ hybridization images for gene expression in the developing and adult mouse nervous system [33] . We found that Dpy30 is mainly expressed in the hippocampus and the cerebellum starting at E15 but it's expression is diminished by early adulthood (P42) ( Figure S1A ).
These results suggest a possible role of Dpy30 during a specific window of brain development.
To determine if Dpy30 is expressed in NSCs, NPCs, and their progeny, we mined a recently published single-cell RNA-sequencing (RNA-seq) dataset of these cells in the mouse neocortex [34] , and found Dpy30 is expressed at the highest level in NSCs and intermediate progenitor cells but low levels in early or late neurons ( Figure S1B ). We also examined the expression of the other core subunits and the catalytic subunits of the Set1/Mll complexes. Interestingly, all of the other core subunits, including Ash2l, Rbbp5, and Wdr5 are expressed at low levels in NSCs, NPCs, and neurons. Among the six catalytic subunits in a Set1/Mll complex, Kmt2a/Mll1, Kmt2c/Mll3, and Kmt2d/Mll4 are expressed at high levels in NSCs, NPCs, and neurons, while Kmt2b/Mll2, Setd1a, and Setd1b are expressed at low levels in these cell types ( Figure S1B ). Dpy30 is thus the only subunit in the Set1/Mll complexes that is preferentially expressed at a high level in NSCs and NPCs, again suggesting an important role of Dpy30 in early stages of neural development.
To further investigate the specific cell types that express Dpy30, we performed immunofluorescence staining of Dpy30 and neuronal nuclei (NeuN), a nuclear marker protein for mature neurons. In the hippocampal dentate gyrus (DG), we saw expression of Dpy30 in both mature granular neurons and cells within the subgranular zone. Dpy30 was also expressed in cells within the subventricular zone (SVZ) and adjacent neuronal layers ( Figure S1C ). As the DG and SVZ are the major areas with significant neurogenesis into adulthood [1] , expression of Dpy30 here prompted us to pursue a functional study of Dpy30 in mammalian brain development and postnatal neurogenesis.
Dpy30 deficiency results in reduction of H3K4 methylation and failure of postnatal neurogenesis
To study the biological function of Dpy30 in postnatal neurogenesis, we used the human glial fibrillary protein (hGFAP)-Cre [35] to excise the floxed Dpy30 allele in NSCs present at embryonic day (E) 13.5 in the dentate, cerebellar granular cell layer, and SVZ [36] . To avoid potential effects from Cre expression, we restricted our comparisons between hGFAP-Cre; Dpy30 F/+ and hGFAPCre; Dpy30 F/− littermates as confirmed by genotyping ( Figure S1D ), hereafter referred to as control and KO, respectively. The KO mice were born at the expected Mendelian ratios and were indistinguishable from their control littermates. However, by postnatal day (P) 5, the KO mice developed progressive but severe growth retardation (Figures S1E and S1F) and ataxia (video S1), and died between P20 and P27. This phenotype is 100% penetrant in a total of over 200 offspring animals. Moreover, we also deleted Dpy30 using Nestin-Cre [37] , whose expression starts E12.5 in cortical prepalate layer and increases during perinatal development in NSCs of the subependymal zone and in NPCs of the rostral migratory stream of newborn mice [38] . The
Nestin-Cre; Dpy30 F/-mice exhibited essentially identical phenotypes of growth retardation ( Figure   S1G ) and ataxia as the hGFAP-Cre; Dpy30 F/-mice, further corroborating a requirement of Dpy30 in postnatal brain development. We have thus only used the hGFAP-Cre; Dpy30
and hGFAP-Cre; Dpy30 F/− (KO) littermates for the rest of this study.
While most of the brain appeared morphologically normal, the hippocampal DG showed grossly altered ultrastructure and the lateral ventricles were enlarged ( Figure 1A ). Moreover, KO mice show a marked reduction in cerebellar folia (marked with the arrows in Figure S1H ) and cells in the internal granular layer (IGL) ( Figure S1I ). Dpy30 mRNA levels were significantly reduced in the KO SVZ and DG ( Figure S1J 
Transcriptome analyses suggest a requirement of Dpy30 for NSPC fate determination
To begin to understand the alterations caused by Dpy30 loss at the molecular level, we examined the gene expression profiles of micro-dissected hippocampal (containing DG) and SVZ tissues extracted from 3 different P12 mice of each genotype via RNA sequencing (RNA-Seq) (Tables   S1 and S2 ). Our Gene Ontology (GO) analysis showed that the top 10 most significantly overrepresented gene functions downregulated in the KO hippocampus were involved in neuronal activities, such as synapse and ion channel activities ( Figure S2A , top left). More specific analyses by Gene Set Enrichment Analysis (GSEA) [39] also revealed significant enrichment of neuronal markers [40] among genes downregulated in the KO hippocampus ( Figure 2A , left), which was confirmed by qPCR for the top group of neuronal marker genes ( Figure S2B and S2C). In addition, some neuronal genes that are not included in the gene set for neuronal markers were also downregulated by Dpy30 loss in the hippocampus. For example, Glutamate Ionotropic Receptor NMDA Type Subunit 2C (Grin2c), a neuronal specific gene [41] , was among the top 50 downregulated genes in KO hippocampus ( Figure S2E , left) and also shown by qPCR to be largely downregulated ( Figure S2C ). Enrichment (but not statistically significant) of astrocytic markers [40] was also observed in genes downregulated in the KO hippocampus ( Figure S2D ).
These results suggest a relatively selective loss of neurogenesis and/or neuronal function in the Dpy30-deficient hippocampus.
On the other hand, the most enriched gene functions downregulated in the KO SVZ were not in mature neuronal activities, but rather included mostly GTPase regulator activities ( Figure S2A , bottom left), which are known to regulate migration of neuronal precursors and neurite outgrowth [42, 43] . Immature neurons/neuroblasts within SVZ travel from SVZ to the olfactory bulb via the rostral migratory stream and differentiate during that process [44] [45] [46] . Indeed, GSEA showed that genes associated with neuroblast migration were significantly enriched among downregulated genes in the KO SVZ, but not in the KO hippocampus ( Figure S2D ). These results suggest the possibility of defective precursor migration from SVZ to the olfactory bulb for differentiation.
Different from the downregulation of neuronal genes in the KO hippocampus, GSEA showed that astrocytic markers [40] were significantly enriched in genes downregulated in the KO SVZ ( Figure   2A , right), which was confirmed by qPCR for the top group of astrocytic marker genes ( Figure   S2B and S2C). Once again, some astrocytic marker genes not included in the gene set were also downregulated in the KO SVZ. For example, Solute Carrier Family 15 Member (Slc15a2), a gene selectively expressed in astrocytes [47] [48] [49] , was among the top 50 most downregulated genes in the KO SVZ ( Figure S2E , right). S100B is another gene that is also specifically expressed in astrocytes [50] . Our qPCR assays confirmed the significant downregulation of both Slc15a2 and S100B in the KO SVZ ( Figure S2C ). We found no significant change in neuronal markers upon loss of Dpy30 in SVZ ( Figure S2D ). These results thus suggest a relatively specific disruption of gliogenesis in the Dpy30-deficient SVZ.
Interestingly, the top enriched gene functions upregulated upon Dpy30 loss in the KO hippocampus and those in the KO SVZ both included mostly ribosomal genes ( Figure S2A , right two panels), suggesting an increase in protein synthesis activity in both of these NSC-related tissues. Consistent with this finding, GSEA also revealed upregulation of activated NSC gene signatures [32] in the KO hippocampus, including genes associated with protein metabolism, mRNA metabolism, and DNA repair ( Figure S2F ). On the other hand, GSEA for the KO SVZ showed downregulation of pathways enriched in quiescent stem cells [32] , such as lipid metabolism, growth factor activity, and Peroxisome Proliferator-Activated Receptor (PPAR) signaling ( Figure S2G ). These results suggest that Dpy30 may regulate the pool of quiescent NSCs in the major postnatal neurogenic regions in brain.
By performing GSEA using a gene set characterized for genes upregulated at prenatal, neonatal, and postnatal developmental stages of the mouse hippocampus [51] , we found enrichment of genes characteristic for prenatal hippocampus in those upregulated in the KO hippocampus, as well as enrichment of genes for postnatal hippocampus in those downregulated the KO hippocampus ( Figure 2B ). For example, Aldolase, Fructose-Bisphosphate C (Aldoc), a gene selectively expressed in the postnatal hippocampus [52] , was among the top 50 downregulated genes in KO hippocampus ( Figure S2E , left) and its significant downregulation was also shown by qPCR ( Figure S2C ). In other words, the gene expression program of the P12 Dpy30-deficient hippocampus resembled a prenatal stage rather than a normal postnatal stage, strongly suggesting a developmental arrest of the Dpy30-deficient hippocampus. Finally, while a NSCspecific signature gene set is not readily available for GSEA, our qPCR assays showed that Prominin1 (Prom1) and Gfap, the coincident expression of which marks adult NSCs in vivo [53] , were both significantly downregulated in the KO SVZ ( Figure S2C ). Although our assays do not provide information on co-expression of both markers in the same cell and Gfap downregulation is more likely a result of reduced gliogenesis, this is consistent with a reduced NSC pool or activity in the KO SVZ.
Dpy30 deficiency impairs neurogenesis and gliogenesis in the postnatal brain
The transcriptome data prompted us to further investigate the effect of Dpy30 loss on NSC activity in the developing brain, especially DG and SVZ. NSCs present in both of these regions express Brain lipid binding protein (Blbp). Consistent with the downregulation of NSC marker Prom1 in the KO SVZ, we found that the Blbp-expressing cell population was significantly reduced in both DG and SVZ of the KO mouse, compared to their corresponding tissues from the control mice ( Figure   2C and 2H). DG of KO mice exhibited reduced immature and mature neuronal populations as seen by doublecortin (Dcx) and NeuN staining, respectively ( Figure 2D and 2E, left, and 2H).
Most striking, however, is the extreme disruption of dentate morphology for both cell groups where it is impossible to distinguish distinct granular and subgranular zones. This is consistent with the reduction of neuronal markers in the KO hippocampus shown by the transcriptome analyses. DG also showed a significant decrease in Gfap-expressing astrocyte population ( Figure 2F , left). Due to differences in the cellular composition around the two neurogenic regions of the postnatal brain Finally, we found that, compared to their corresponding control tissues, both the DG and SVZ from the KO mice had significantly less actively dividing cells expressing proliferation protein Ki-67 ( Figures 2G and 2H ) [55] that is also functionally crucial for cell division by maintaining the structural integrity of mitotic chromosomes [56] . Therefore, Dpy30 is required to generate or maintain the pool of proliferative NSCs.
Dpy30 is required for sustaining self-renewal and proliferation of NSPCs in vitro.
To determine whether Dpy30 is cell-intrinsically required for self-renewal of NSCs, we extracted
NSCs from SVZ of KO mice, and measured their self-renewal using the neurosphere serial replating assay ( Figure 3A ) [12, 57] . We first confirmed our technical ability to isolate and grow multipotent control neurospheres. Control neurospheres differentiated into both neuronal and glial lineages with characteristic cell morphologies and lineage markers upon appropriate treatment ( Figure 3B and S3A) . However, KO neurospheres show low viability which precluded detailed analysis of neurospheres. We did note that serial re-plating assays of the KO cells showed a significant reduction in both the number and size of neurospheres compared to the control cells in each of the same passages ( Figure 3C and 3D) , and unlike controls, there were no live cells in the KO culture after the 5th passage ( Figure 3C Figure 3E ). Moreover, percentage of the Ki-67-positive cells was also significantly reduced by Dpy30 KD in these cells ( Figure 3F ). This suggests that Dpy30 is required for maintaining the NSPC proliferation.
Dpy30 directly regulates differentiation of NPCs to neuronal and glial lineages
We next studied the effect of Dpy30 KD on the differentiation of these cultured NPC lines. Upon These results suggest inefficient neuronal differentiation of the human NPCs upon DPY30 KD.
We also examined the effect of depletion of ASH2L, the direct interaction partner of DPY30 and also a core subunit of the SET1/MLL complexes [58] in human NPCs. While we were able to achieve approximately 50% KD efficiency before differentiation, the KD efficiency became very low after treatment of differentiation conditions ( Figure S4C ), suggesting that cells with efficient ASH2L depletion were not compatible with the differentiation conditions and were likely selected against during the process.
To further understand the differentiation defect of Dpy30-KD mouse and human NPCs, we analyzed the expression change of a number of genes known to regulate NSC or NPC fate determination. These genes include NEUROD1 [59] and NEUROG1 [60] , which encode E-boxbinding transcriptional activators critical for neuronal differentiation, and MAP2, which encodes a cytoskeletal protein determining and stabilizing dendritic shape during neuron development [61] .
We did not find downregulation of some of these genes in the micro-dissected Dpy30 KO hippocampal or SVZ tissues ( Figure S2C ), and suspected that contamination of Dpy30-intact cells may contribute to the lack of downregulation, and thus sought to investigate these genes in the much more homogenous cell lines in culture. These genes were induced after differentiation in the control cells but failed to be induced under the same differentiation conditions in both mouse and human NPCs depleted of Dpy30 ( Figure 4B and 4F). We also examined the expression change of genes involved in gliogenesis such as GFAP and S100B. Similar to the effect on the neurogenic genes, GFAP expression was elevated upon differentiation of control NPCs, but such induction was significantly impaired or completely lost in NPCs depleted of Dpy30 ( Figure 4B and 4F). The expression of S100B was significantly reduced by DPY30 KD before differentiation, and this reduction became more prominent after differentiation of the human NPCs ( Figure 4F ). Even in the cells that started with decent but ended with minimal depletion of ASH2L under the differentiation conditions, the expression of both the neurogenic and gliogenic genes was modestly impaired compared to the control at the end of the differentiation process ( Figure S4C ).
These results indicate a requirement of the mammalian H3K4 methyltransferase complexes in efficient expression of the lineage specification genes during NPC fate determination.
As shown by Chromatin immunoprecipitation (ChIP) assays, Dpy30 bound to the transcriptional start sites (TSSs) of these genes ( Figure 4C and 4G, top, and S4D and S4E, top) in at least one of the NPC models, suggesting that Dpy30 directly controls the expression of these key neurogenesis genes. As a consequence of reduced Dpy30 binding to these genes upon Dpy30 KD, H3K4me3 was reduced at many of these genes ( Figure 4C and 4G, bottom, and S4D and including the NURF chromatin-remodeling complexes and AKAP95 [14, 65] . We thus cannot exclude a role of Dpy30 in NSC regulation through interacting with these factors.
CONCLUSION
In summary, by using both genetic inactivation in mouse and in vitro assays, our studies uncover a profound requirement of Dpy30 and its associated H3K4 methylation in sustaining the functionality of NSCs through regulating both the self-renewal and lineage differentiation capacities. This knowledge may have implications in neurodevelopmental disorders associated with mutations in the writers, erasers, and readers of H3K4 methylation.
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significantly downregulated over 2 fold in the KO hippocampus ("Hippo DN in KO>2 fold p<0. Gfap  AACAACCTGGCTGCGTATAG  TCTCGAACTTCCTCCTCATAGAT  expression  mouse  Map2  GAGGCAGTAAGTGAAAGGAGAG  GCATCTCAACCTCGGCTATT  expression  mouse  Neurod1  GCTACTCCAAGACCCAGAAAC  TGTACGAAGGAGACCAGATCA  expression  mouse  Neurog1  CCGCATGCACAACCTAAAC  GTGAGCGCCCAGATGTAAT  expression  mouse  Dpy30  ACCCTCACTCTGAGTACGGG  GGACTGTAGATCCACCTTCTGT  expression  mouse  S100b  TGGTTGCCCTCATTGATGTCT  CCCATCCCCATCTTCGTCC  expression  mouse  Grin2c  GCCCTGCTTCTCACTTCACTC  GTTGGTATTGTTGACCCCGAT  expression  mouse  Aldoc  AGAAGGAGTTGTCGGATATTGCT  TTCTCCACCCCAATTTGGCTC  expression  mouse  Nefl  CCGTACTTTTCGACCTCCTACA  CTTGTGTGCGGATAGACTTGAG  expression  mouse  Tuba4a  ATGCGCGAGTGCATTTCAG  CACCAATGGTCTTATCGCTGG  expression  mouse  Ptprn  CTTGTGTATGCGCCATCATTCG  GGTCCTGGTACTCAAAAGTAGTG  expression  mouse  Gpr162  CTCCCTACGCTCAAACGCATT  CCGCCATGAGTATATGAGTACCG  expression  mouse  Cplx1  AGTTCGTGATGAAACAAGCCC  TCTTCCTCCTTCTTAGCAGCA  expression  mouse  Chn1  GGGGAGGAAAGCTAACAGAGC  ACTTTTGAGAGCCCAGTTTCATT  expression  mouse  Clstn3  GGACAAGGCAACGGGTGAA  GCCACAGTCATAAGCCTGAATG  expression  mouse  Syp  CAGTTCCGGGTGGTCAAGG  ACTCTCCGTCTTGTTGGCAC  expression  mouse  Slc15a2  GGCACGGACTAGATACTTCTCG  AACGGCTGTTCACATCCTTTT  expression  mouse  Prom1  CTCCCATCAGTGGATAGAGAACT  ATACCCCCTTTTGACGAGGCT   expression   mouse  Glu  TGAACAAAGGCATCAAGCAAATG  CAGTCCAGGGTACGGGTCTT  expression  mouse  Atp13a5  GAGGTGTTTGGCTACCATACC  GGGATGCAACTGGTCCACA  expression  mouse  Stab1  GGCAGACGGTACGGTCTAAAC  AGCGGCAGTCCAGAAGTATCT  expression  mouse  Sparcl1  GGCAATCCCGACAAGTACAAG  TGGTTTTCTATGTCTGCTGTAGC  expression  mouse  Itgam  ATGGACGCTGATGGCAATACC  TCCCCATTCACGTCTCCCA  expression  mouse  Pla2g7  CTTTTCACTGGCAAGACACATCT  CGACGGGGTACGATCCATTTC  expression  mouse  Atp1A2  CCACCACTGCGGAAAATGG  GCCCTTAGACAGATCCACTTGG  expression  mouse  Gja1  ACAGCGGTTGAGTCAGCTTG  GAGAGATGGGGAAGGACTTGT  expression mRNA levels in the neurogenic regions of P12 mice were determined by qPCR and normalized to Actb. n = 11 for SVZ, n = 3 for DG, for each genotype. Data represent the mean ± SD for (J). **P < 0.01 and ***P < 0.001, by two-tailed Student's t test for (E) and (J). Figure 2A . Genes marked with red arrows were used for analysis in (C). (C) Relative mRNA levels of selected genes were determined by qPCR and normalized to Gapdh. n = 3 mice each genetype for hippocampus. n = 12 (control) or 11 (KO) mice for SVZ. Genes include those from 'Astrocytic marker' and 'Neuronal marker' gene sets in (B) and from the top 50 up-or down-regulated genes shown in (E). (E) Heatmaps of the top 50 down-and upregulated genes (P < 0.001) following Dpy30 KO in hippocampus (left) and SVZ (right) tissues. Genes marked with red arrows were used in (C). (D and F-H) GSEA on RNA-seq results obtained from SVZ and hippocampus of P12 control and KO mice. 'Astrocyte marker' gene set and 'neuronal marker' gene set (Lein et al., 2007) and curated neuroblast migration gene set were used for (D). 'Active NSC' gene sets and 'quiescent NSC' gene sets (Codega et al., 2014) were used for (F) and (G), respectively. H3K4me3 broad peaks in mNPC gene set (Benayoun et al., 2014) were used for (H). Data represent the mean ± SD in (C). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, and *****P < 0.00001, by two-tailed Student's t test for (C). Figure 4C and 4G in (D) and (E), respectively. Data represent the mean ± SD from 3 biological repeats for (C). *P < 0.05, by two factor ANOVA analysis followed with post hoc t-Test for (C). 
